Condensed Consolidated Statements of Operations and Comprehensive Earnings (Loss) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2016	Mar. 31, 2015	Mar. 31, 2016	Mar. 31, 2015
Income Statement [Abstract]
Operating revenues (net of contractual allowances)	$ 20,734	$ 25,196	$ 64,421	$ 74,913
Less provision for bad debts of Healthcare Facilities Segment	759	1,845	3,692	6,060
Net revenues	19,975	23,351	60,729	68,853
Costs and Expenses
Cost of goods sold	5,614	6,181	15,582	16,253
Salaries, wages and benefits	9,887	10,729	30,787	32,135
Provision for bad debts of Specialty Pharmacy Segment	69	65	429	188
Supplies	1,347	1,702	4,654	5,546
Purchased services	1,138	1,382	3,722	3,880
Other operating expenses	2,508	2,696	7,778	7,036
Rent and lease expense	302	343	945	1,020
Insurance settlement	0	0	0	(1,000)
EHR incentive payments	0	(64)	100	(64)
Depreciation and amortization	618	602	1,778	1,817
Operating Profit (Loss)	(1,508)	(285)	(5,046)	2,042
Other Income, (Expense):
Gain on sale of assets	5	13	12	13
Interest expense - net	(211)	(213)	(637)	(677)
Earnings (Loss) from Continuing Operations before income taxes	(1,714)	(485)	(5,671)	1,378
Income Tax Expense (Benefit)	0	(169)	6,852	816
Earnings (Loss) from Continuing Operations	(1,714)	(316)	(12,523)	562
Loss from Discontinued Operations, net of tax	(121)	(95)	(326)	(409)
Net Earnings (Loss)	(1,835)	(411)	(12,849)	153
Other comprehensive income	0	0	0	0
Comprehensive Earnings (Loss)	$ (1,835)	$ (411)	$ (12,849)	$ 153
Continuing Operations:
Basic	$ (0.18)	$ (0.03)	$ (1.33)	$ 0.06
Diluted	(0.18)	(0.03)	(1.33)	0.06
Discontinued Operations:
Basic	(0.01)	(0.01)	(0.03)	(0.04)
Diluted	(0.01)	(0.01)	(0.03)	(0.04)
Net Earnings (Loss):
Basic	(0.19)	(0.04)	(1.36)	0.02
Diluted	$ (0.19)	$ (0.04)	$ (1.36)	$ 0.02
Weighted-Average Common Shares Outstanding:
Basic	9,443	9,443	9,443	9,443
Diluted	9,443	9,443	9,443	9,481